Jon Wigginton

Jon Wigginton

Company: Cullinan Oncology

Job title: Chairman, Scientific Advisory Board and Senior Advisor


Cancer Immunotherapy for Head and Neck Cancer: Current Status and Future Opportunities 10:45 am

Exciting new advances have been made in the application of cancer immunotherapy for the treatment of head and neck cancer, including strategies encompassing both innate and adaptive immunity. This presentation will assess the current state of the field, key questions and future opportunities for cancer immunotherapy in patients with head and neck cancerRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.